Gavin Wood - Net Worth and Insider Trading
Gavin Wood Net Worth
The estimated net worth of Gavin Wood is at least $286,572 dollars as of 2024-12-28. Gavin Wood is the CFO of Affymetrix Inc and owns about 16,412 shares of Affymetrix Inc (AFFX) stock worth over $229,932. Gavin Wood is also the CFO of Adaptimmune Therapeutics PLC and owns about 96,000 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $56,640. Details can be seen in Gavin Wood's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gavin Wood has not made any transactions after 2022-05-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gavin Wood
Gavin Wood Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gavin Wood owns 2 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , and Affymetrix Inc (AFFX) .
Click here to see the complete history of Gavin Wood’s form 4 insider trades.
Insider Ownership Summary of Gavin Wood
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2022-05-20 | Chief Financial Officer |
| AFFX | Affymetrix Inc | 2016-03-31 | EVP & Chief Financial Officer |
Gavin Wood Latest Holdings Summary
Gavin Wood currently owns a total of 2 stocks. Among these stocks, Gavin Wood owns 16,412 shares of Affymetrix Inc (AFFX) as of May 20, 2013, with a value of $229,932 and a weighting of 80.24%. Gavin Wood also owns 96,000 shares of Adaptimmune Therapeutics PLC (ADAP) as of May 20, 2022, with a value of $56,640 and a weighting of 19.76%.
Latest Holdings of Gavin Wood
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AFFX | Affymetrix Inc | 2013-05-20 | 16,412 | 14.01 | 229,932 |
| ADAP | Adaptimmune Therapeutics PLC | 2022-05-20 | 96,000 | 0.59 | 56,640 |
Holding Weightings of Gavin Wood
Gavin Wood Form 4 Trading Tracker
According to the SEC Form 4 filings, Gavin Wood has made a total of 0 transactions in Affymetrix Inc (AFFX) over the past 5 years. The most-recent trade in Affymetrix Inc is the sale of 0 shares on May 20, 2013, which brought Gavin Wood around $0.
According to the SEC Form 4 filings, Gavin Wood has made a total of 3 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 39,000 shares on May 20, 2022, which cost Gavin Wood around $11,310.
Insider Trading History of Gavin Wood
- 1
Gavin Wood Trading Performance
GuruFocus tracks the stock performance after each of Gavin Wood's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gavin Wood is 14.92%. GuruFocus also compares Gavin Wood's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gavin Wood within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gavin Wood's insider trading performs compared to the benchmark.
Performance of Gavin Wood
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.96 | | | | | |
| Relative Return to S&P 500(%) | 16.3 | | | | | |
Gavin Wood Ownership Network
Gavin Wood Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Gavin Wood is the Chief Financial Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Gavin Wood made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 70,989 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,531 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,531 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Gavin Wood Mailing Address
Above is the net worth, insider trading, and ownership report for Gavin Wood. You might contact Gavin Wood via mailing address: C/o Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire X0 Ox14 4rx.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
